The IRF2BPL gene helps control which other genes are switched on in nerve cells and supports normal brain function. This gene plays an important role in keeping brain cells working over time. If the IRF2BPL gene does not work properly, a person may have developmental delay, seizures, trouble with balance or movement, and sometimes a loss of skills after early childhood. Pathogenic variants in this gene are linked to a rare genetic condition affecting the brain and nervous system.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing processes in the body. Some genes carry the information needed to make proteins, which do much of the cell’s work. Others mainly regulate when certain activities happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
IRF2BPLGene function
What if the gene works
The IRF2BPL gene helps control which other genes are switched on or off, especially in nerve cells. Its protein also helps manage protein cleanup inside cells, which supports healthy brain development and nerve cell function.
Risk
What if the gene does not work
Variants in the IRF2BPL gene can cause a neurodevelopmental condition with developmental delay, loss of skills, seizures, and movement problems. Milder variants may cause later, less extensive symptoms, while more disruptive variants often affect children earlier.
Treatment
What does that mean for your treatment
No treatment or management approach specific to pathogenic variants in the IRF2BPL gene is currently established. The IRF2BPL gene is being studied in early-stage research as a possible future treatment target in nerve cells, but this has not yet changed clinical care.
Conditions associated with IRF2BPL
Gene function
What if the gene works
In your cells, the IRF2BPL gene helps manage routine control systems that keep other genes and proteins in balance. Its protein mainly works in the nucleus, where cells handle genetic instructions. This steady control is especially important for normal brain cell function.
The IRF2BPL gene helps control how strongly certain other genes are turned on or off. This helps cells use the right instructions at the right time.
Through a protein tagging system, IRF2BPL helps manage which proteins stay active and which are cleared away. This supports orderly cell signaling and routine cell maintenance.
Steady IRF2BPL activity helps support normal brain cell function by keeping gene use and protein handling organized. That matters in nerve cells, which need stable day to day upkeep over many years.
What is a variant?
A genetic variant means a slight change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. At times, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many pathogenic variants in the IRF2BPL gene shorten the protein or make it break down early, so cells are left with too little working protein. In descriptions of how IRF2BPL gene variants affect the protein, milder single-letter changes may leave some activity, while more disruptive changes that create an early stop signal often cause a larger loss of function. This difference may disturb cell control to different degrees and can relate to earlier onset or more marked neurologic features.
How variants are linked to conditions
Pathogenic variants in the IRF2BPL gene cause a rare neurodevelopmental condition, often called NEDAMSS, and IRF2BPL gene variants are linked to developmental delay, seizures, movement problems, and loss of speech or other learned skills. Some people have a milder presentation, while others develop a more progressive course over time. Reported features can also include balance problems and learning difficulties.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a part. In some situations, though, one well-characterized variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks linked to the IRF2BPL gene. In families with a harmful IRF2BPL change, risk is mainly shaped by the genetic change itself rather than lifestyle or environment, so ongoing medical follow-up is often the most useful step.
Inheritance of IRF2BPL variants
IRF2BPL-related conditions are usually inherited in an autosomal dominant pattern, which means a child can be affected if they inherit one altered copy of the IRF2BPL gene. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. In many families, though, the answer to how IRF2BPL variants are inherited includes a new, de novo variant, meaning the change started in the child and was not inherited from either parent. Boys and girls can inherit and pass on IRF2BPL variants equally.
What does my IRF2BPL result mean for my family?
For IRF2BPL, a harmful result is usually linked to a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to discuss family testing. At the same time, many known IRF2BPL cases happen because of a new gene change in the affected person, meaning neither parent carries it. The meaning for children and other relatives depends on whether the change was inherited or started new in that person.
Genetic information
Genetic testing
How you find out about variants
Variants in the IRF2BPL gene are found with genetic testing, usually from a blood sample or saliva. IRF2BPL genetic testing often uses a multigene panel, exome sequencing, or whole genome sequencing to read your DNA and look for variants. Results may identify a disease causing variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the IRF2BPL gene may be considered when a child has unexplained developmental delay, loss of skills over time, seizures, or new balance and movement problems. It can also help clarify the cause of these symptoms even when there is no family history.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help place a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly, while others process it faster or are more sensitive to its effects. This helps explain why the same treatment may work well for one person, have less effect for another, or cause more side effects in someone else. These differences are common and are one part of the reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It focuses on links between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can affect both how strongly a drug works and how the body handles it. This information can help guide treatment choices that are more informed and tailored to the individual. More detail on this topic is available in the LearnHub.
Drugs influenced by the IRF2BPL gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how well they work. Questions about side effects, new symptoms after starting treatment, or concerns about how a medication may affect you are best discussed with your doctor or pharmacist.
History
IRF2BPL entered the medical literature under earlier names, including EAP1, during research on how genes influence brain-related signaling and the timing of puberty. Over time, scientists’ understanding of the gene’s function has changed. A major turning point came in the late 2010s, when sequencing studies linked harmful variants in the IRF2BPL gene to a rare neurodevelopmental condition with developmental delay, seizures, and movement problems. Those reports helped connect earlier laboratory work with real clinical findings in children and families. Since then, case reports from different countries have steadily expanded the picture of how changes in this gene can affect health.